Hemangioblastic characteristics of fetal bone marrow-derived Flk1+CD31-CD34- cells

Experimental Hematology

Volumn 31, Issue 7, 2003, Pages 650-658

  Guo, Hong ^a   Fang, Baijun ^a   Liao, Lianming ^a   Zhao, Zhigang ^a   Liu, Jiewen ^a   Chen, Huishu ^a   Hsu, Steven H ^a   Cui, Qi ^a   Zhao, Robort Chunhua ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA GLOBIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; GAMMA GLOBIN; HEMOPOIETIC GROWTH FACTOR; METHYLCELLULOSE; PROTEIN GLYA; SURAMIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANTIGEN DETECTION; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL SELECTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ERYTHROID CELL; EXTRACELLULAR MATRIX; FETUS; FETUS CELL; GEL; HEMANGIOBLAST; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; MAGNETISM; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STEM CELL;

EID: 0038722035     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00087-0     Document Type: Article

References (49)

1. Palis J., Mcgrath K.E., Kingsley P.D. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. Blood. 86:1995;156-163.
2. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculargenesis in Flk1-deficient mice. Nature. 376:1995;62-66.
3. rd, Kieran M.W., Chan F.Y., et al. Intraembryonic hematopoietic cell migration during vertebrate development. Proc Natl Acad Sci USA. 92:1995;10713-10717.
4. Caprioli A., Minko K., Drevon C., Eichmann A., Dieterlen-Lievre F., Jaffredo T. Hemangioblast commitment in the avian allantois: cellular and molecular aspects. Dev Biol. 238:2001;64-78.
5. Yano M., Iwama A., Nishio H., Suda J., Takada J., Suda T. Expression and function of murine receptor tyrosine kinases, TIE and TEK, inhematopoietic stem cells. Blood. 89:1997;4317-4326.
6. Terman B.I., Dougher-Vermazen M., Carrion M.E., et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun. 187:1992;1579-1586.
7. Begley C.G., Green A.R. The SCL gene: from case report to critical hematopoietic regulator. Blood. 93:1999;2760-2770.
8. Anagnostou A., Liu Z., Steiner M., et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA. 91:1994;3974-3978.
9. Eichmann A., Corbel C., Nataf V., Vaigot P., Breant C., Le Douarin N.M. Ligand-dependent of the endothelial and hematopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor 2. Proc Natl Acad Sci USA. 94:1997;5141-5146.
10. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:1997;981-990.
11. Liao E.C., Paw B.H., Oates A.C., Pratt S.J., Postlethwait J.H., Zon L.I. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev. 12:1998;621-626.
12. Robertson S.M., Kennedy M., Shannon J.M., Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 127:2000;2447-2459.
13. Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 98:2001;2615-2625.
14. Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 105:2000;71-77.
15. Davey F.R., Olson S., Kurec A.S., Eastman-Abaya R., Gottlieb A.J., Mason D.Y. The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. Am J Surg Pathol. 12:1988;699-707.
16. Conget P.A., Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 181:1999;67-73.
17. Zon L.I. Developmental biology of hematopoiesis. Blood. 86:1995;2876-2891.
18. Solovey A., Lin Y., Browne P., Choong S., Wayner E., Hebbel R.P. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 337:1997;1584-1590.
19. Sbarbati R., de Boer M., Marzilli M., Scarlattini M., Rossi G., van Mourik J.A. Immunologic detection of endothelial cells in human whole blood. Blood. 77:1999;764-769.
20. + cells identifies a population of functional endothelial precursors. Blood. 95:2000;952-958.
21. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183:1996;1797-1806.
22. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:2001;1395-1402.
23. Grant M.B., May W.S., Caballero S., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 8:2002;607-612.
24. Pelosi E., Valtieri M., Coppola S., et al. Identification of the hemangioblast in postnatal life. Blood. 100:2002;3203-3208.
25. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;45-57.
26. Robb L., Lyons I., Li R., et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA. 92:1995;7075-7079.
27. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development. 125:1998;725-732.
28. -/- embryonic stem cells andembryos. Proc Natl Acad Sci USA. 96:1999;2159-2164.
29. Romeo P.H., Prandini M.H., Joulin V., et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature. 344:1990;447-449.
30. Orkin S.H. GATA-binding transcription factors in hematopoietic cells. Blood. 80:1992;575-581.
31. Pevny L., Simon M.C., Robertson E., et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:1991;257-260.
32. Pevny L., Lin C.S., D'Agati V., Simon M.C., Orkin S.H., Costantini F. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 121:1995;163-172.
33. Tsai F.Y., Keller G., Kuo F.C., et al. An early haematopoietic defect inmice lacking the transcription factor GATA-2. Nature. 371:1994;221-226.
34. Leonard M., Brice M., Engel J.D., Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood. 82:1993;1071-1079.
35. Orlic D., Anderson S., Biesecker L.G., Sorrentino B.P., Bodine D.M. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci USA. 92:1995;4601-4605.
36. Cheng T., Shen H., Giokas D., Gere J., Tenen D.G., Scadden D.T. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci USA. 93:1996;13158-13163.
37. Young P.E., Baumhueter S., Lasky L.A. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood. 85:1995;96-105.
38. - blood-derived human endothelial cell progenitors. Stem Cells. 19:2001;304-312.
39. -/low hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells. 18:2000;252-260.
40. low/negative hematopoietic stem cells. Science. 273:1996;242-245.
41. negative/low hematopoietic stem cells in multiple species. Nat Med. 3:1997;1337-1345.
42. Bhatia M., Bonnet D., Murdoch B., Gan O.I., Dick J.E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 4:1998;1038-1045.
43. + cells. Exp Hematol. 26:1998;353-360.
44. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science. 284:1999;143-147.
45. Jackson K.A., Mi T., Goodell M.A. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA. 96:1999;14482-14486.
46. Hu Y., Mu L., Ma G.J., Jiang X.Y., Zhao C.H. Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice. Acta Academine Medicine Sinicae. 24:2002;20.
47. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 30:2002;896-904.
48. Hu, Y, Liao, L, Wang, Q, et al., Isolation and identification of mesenchymal stem cells from human fetal pancreas. J Lab Clin Med (in press).
49. Guo H., Hu Y., Liao L.M., et al. Postembryonic subtotipotent stem cells derived from a variety of fetal tissues have multiple differentiation potential and greatly contribute to stem cell plasticity. China Journal of Modern Medicine. 12:2002;1-6.